Wipro named leader in healthcare robotic process automation

The report evaluated the current offering, market presence and strategy of 12 of the most significant emerging Robotic Process Automation (RPA) service providers in HCLS.

In addition to being named a leader, Wipro received differentiated ratings in the intelligent automation, attended automation, unattended automation, HCLS Automation, Knowledge Transfer and commercial model criteria.

The Forrester report stated that, ‘Of all the vendors [Forrester] evaluated, Wipro has the most experience building bots for HCLS clients and delivering automations to HCLS clients under outcomes-based procurement models’. The report also noted, ‘Clients said that Wipro is their trusted strategic advisor on new [Artificial Intelligence] (AI) technologies and emerging governance models’.

"The COVID-19 pandemic is forcing healthcare organisations (HCOs) to scale operations to care for an unprecedented number of patients. The entire healthcare value chain is under scrutiny for opportunities to increase throughput and carve out cost. Life sciences organisations face pressure to accelerate research, manufacturing, and distribution…COVID-19 will eventually pass, but the automation tools and strategies being deployed today are here to stay," said the report authored by Jeff Becker, Senior Analyst, Forrester Research.

The report later noted: "Wipro is an all-purpose service provider; it's a strong fit for enterprises that need strategic governance advice or those that just need a team of bot developers willing to work at risk."

Bill Stith, Senior Vice President and Global Head, Health Business Unit, Wipro, added: "As we navigate the current challenges, we continue to invest in co-innovation with our clients and extended partner ecosystem to empower the global health workforce. We provide automation architectures, governance frameworks and machine-learning-based decision management which can be scaled at velocity, so their time is freed to address greater health challenges.

“We continue to discover, analyse and design new automated processes and intuitive artificial intelligence interventions, across the care continuum from clinical trials to care delivery to claims processing, offering these through creative servicing models. We believe this recognition exemplifies our market leadership in this segment of digital health."